New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
09:03 EDTMDXGMiMedx reimbursement in Florida a positive, says Lake Street
Lake Street views the expanded reimbursement announced by MiMedx for its EpiFix as a positive for the stock as Florida is a large potential market. The firm expects significant market share gains in 2014 for MiMedx and maintains a Buy rating and $9 price target on the stock.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 1, 2015
10:06 EDTMDXGMiMedx says EpiFix gains added coverage from commercial health plans
MiMedx Group announced an update of its products' coverage by commercial health plans. MiMedx reports that 168 commercial health plans representing 170.4M covered lives are currently providing insurance coverage for the company's allografts. Within these 168 commercial health plans, Blue Cross/Blue Shield plans encompassing 45 states plus the District of Columbia also provide insurance coverage for their members to be treated with MiMedx allografts. Additionally, 36M Medicare and 49.1M Medicaid beneficiaries have insurance coverage provided for the company's allografts as of this time. Parker "Pete" Petit, Chairman and CEO, stated, "Since we last provided an update of the status of reimbursement coverage for our EpiFix allografts, we have made further advances in gaining additional coverage from commercial health plans. Recently, we added another major national commercial health plan along with a number of regional commercial plans. These additional commercial health plans adding MiMedx allografts to their coverage policies increased the number of covered lives by close to 9M over the covered lives we reported in our press release of October 29, 2015."
November 19, 2015
18:10 EDTMDXGMiMedx awarded 12 new U.S. patents year-to-date
Subscribe for More Information
November 17, 2015
09:30 EDTMDXGMiMedx to present sixteen poster abstracts at Desert Foot Conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use